Treatment cuts migraine days by half
A new King’s College London study, published in the New England Journal of Medicine (NEJM), shows treatment with a drug called erenumab cut the number of days with migraine symptoms for 50 per cent of patients.
By NIHR Maudsley BRC at 30 Nov 2017